NMRA
Neumora Therapeutics Inc.
Company Overview
| Mkt Cap | $419.44M | Price | $3.02 |
| Volume | 4.58M | Change | +3.07% |
| P/E Ratio | -1.7 | Open | $3.00 |
| Revenue | -- | Prev Close | $2.93 |
| Net Income | $-243.8M | 52W Range | $0.61 - $14.09 |
| Div Yield | N/A | Target | $7.00 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated DailyNeumora Therapeutics Inc. (NMRA) is a leading diversified company in the business industry, currently trading at $3.02 with a market capitalization of $419.44 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows NMRA with a volume of 4.58 million shares. The stock opened up 2.39% from yesterday's close of $2.93. Current analyst estimates project earnings of $-1.43 per share for this year, with next year targeting $-1.08.
NMRA demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for NMRA include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 131.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 04:36 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $3.02 | +3.1% | 4.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW